Skip to main content

Advertisement

Log in

Research on construction and identification of lentiviral vector of expressing miRNA targeting IGF1R gene regulated by survivin promoter and its inhibition to liver cancer cell growth

  • Published:
The Chinese-German Journal of Clinical Oncology

Abstract

Objective

The aim of the study was to investigate the interference and anti-tumor effects of lentiviral vector of miRNA targeting IGF1R gene regulated by survivin promoter.

Methods

The fragment of the survivin promoter was acquired by PCR amplification and inserted into pPRIME to recombinant plasmid sur-pPRIME. The complementary DNA containing both sense and antisense Oligo DNA of the targeting sequence was designed, synthesized and cloned into the sur-pPRIME vector, named sur-pPRIME-IGF1R-miR30-shRNA. Viruses were propagated on 293T cells. Viruses were purified by CsCI gradient according to standard techniques, and functional PFU titers were determined by plaque assay on 293 cells. The effect of sur-pPRIME-IGF1R-miR30-shRNA on IGF1R expression of Hep3B cells was detected by RT-PCR and Western blot. The antitumor potential of sur-pPRIME-IGF1R-miR30-shRNA to Hep3B cells was evaluated by CCK-8 assay.

Results

sur-pPRIME-IGF1R-miR30-shRNA was constructed successfully. Functional PFU titers of sur-pPRIME-IGF1R-miR30-shRNA were 4.58×109 PFU/mL. Sur-pPRIME-IGF1R-miR30-shRNA was more effective to inhibit IGF1R expression in mRNA or protein levels and the proliferation of Hep3B cells.

Conclusion

sur-pPRIME-IGF1R-miR30-shRNA expressing IGF1R-siRNA can inhibit IGF1R expression and may be used for further investigation of gene therapy of liver cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fang L, Pu YY, Hu XC, et al. Antiangiogenesis gene armed tumor-targeting adenovirus yields multiple antitumor activities in human HCC xenografts in nude mice. Hepatol Res, 2010, 40: 216–228.

    Article  PubMed  CAS  Google Scholar 

  2. Konno R, Yamakawa H, Utsunomiya H, et al. Expression of survivin and Bcl-2 in the normal human endometrium. Mol Hum Reprod, 2000, 6: 529–534.

    Article  PubMed  CAS  Google Scholar 

  3. Jeha S, Luo XN, Beran M, et al. Antisense RNA inhibition of phosphoprotein p18 expression abrogates the transformed phenotype of leukemic cells. Cancer Res, 1996, 56: 1445–1450.

    PubMed  CAS  Google Scholar 

  4. Su CQ, Na ML, Chen J, et al. Gene-viral cancer therapy using dualregulated oncolytic adenovirus with antiangiogenesis gene for increased efficacy. Mol Cancer Res, 2008, 6: 568–575.

    Article  PubMed  CAS  Google Scholar 

  5. Lange SS, Takata K, Wood RD. DNA polymerases and cancer. Nat Rev Cancer, 2011, 11: 96–110.

    Article  PubMed  CAS  Google Scholar 

  6. Lois C, Hong EJ, Pease S, et al. Germline transmission and tissuespecific expression of transgenes delivered by lentiviral vectors. Science, 2002, 295: 868–872.

    Article  PubMed  CAS  Google Scholar 

  7. Pfeifer A, Ikawa M, Dayn Y, et al. Transegenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc Natl Acad Sci USA, 2002, 99: 2140–2145.

    Article  PubMed  CAS  Google Scholar 

  8. Lai Z, Brady RO. Gene transfer into the central nervous system in vivo using a recombinant lentivirus vector. J Neurosci Res, 2002, 67: 363–371.

    Article  PubMed  CAS  Google Scholar 

  9. Zufferey R, Dull T, Mandel RJ, et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol, 1998, 72: 9873–9880.

    PubMed  CAS  Google Scholar 

  10. Yu X, Zhan X, D’Costa J, et al. Lentiviral vectrs with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells. Mol Ther, 2003, 7: 827–838.

    Article  PubMed  CAS  Google Scholar 

  11. Zhao J, Pettigrew GJ, Thomas J, et al. Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo. Basic Res Cardiol, 2002, 97: 348–358.

    Article  PubMed  CAS  Google Scholar 

  12. Bauer G, Dao MA, Case SS, et al. In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors. Mol Ther, 2008, 16: 1308–1315.

    Article  PubMed  CAS  Google Scholar 

  13. Baba K, Goto-Koshino Y, Mizukoshi F, et al. Inhibition of the replication of feline immunodeficiency virus by lentiviral vector-mediated RNA interference in feline cell lines. J Vet Med Sci, 2008, 70: 777–783.

    Article  PubMed  CAS  Google Scholar 

  14. Zeng Y. Principles of micro-RNA production and maturation. Oncogene, 2006, 25: 6156–6162.

    Article  PubMed  CAS  Google Scholar 

  15. Navarro M, Baserga R. Limited redundancy of survival singals from the type 1 insulin-like growth factors receptor. Endocrinology, 2001, 142: 1073–1081.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jian Niu.

Additional information

Supported by the grants from the Education Departmental Natural Science Research Funds of Jiangsu Provincial Higher School of China (No. 09KJB320018, No. 09KJB310016).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Niu, J., Liu, Z., Song, Y. et al. Research on construction and identification of lentiviral vector of expressing miRNA targeting IGF1R gene regulated by survivin promoter and its inhibition to liver cancer cell growth. Chin. -Ger. J. Clin. Oncol. 10, 705–710 (2011). https://doi.org/10.1007/s10330-011-0867-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10330-011-0867-7

Key words

Navigation